Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 2
2014 1
2015 3
2016 2
2017 3
2018 4
2019 3
2020 2
2021 4
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond.
Mahlapuu M, Caputo M, Xia Y, Cansby E. Mahlapuu M, et al. Among authors: cansby e. Hepatol Commun. 2022 Oct;6(10):2613-2622. doi: 10.1002/hep4.2013. Epub 2022 May 31. Hepatol Commun. 2022. PMID: 35641240 Free PMC article. Review.
STE20-type kinase TAOK3 regulates hepatic lipid partitioning.
Xia Y, Caputo M, Cansby E, Anand SK, Sütt S, Henricsson M, Porosk R, Marschall HU, Blüher M, Mahlapuu M. Xia Y, et al. Among authors: cansby e. Mol Metab. 2021 Dec;54:101353. doi: 10.1016/j.molmet.2021.101353. Epub 2021 Oct 8. Mol Metab. 2021. PMID: 34634521 Free PMC article.
STK25 regulates oxidative capacity and metabolic efficiency in adipose tissue.
Sütt S, Cansby E, Paul A, Amrutkar M, Nuñez-Durán E, Kulkarni NM, Ståhlman M, Borén J, Laurencikiene J, Howell BW, Enerbäck S, Mahlapuu M. Sütt S, et al. Among authors: cansby e. J Endocrinol. 2018 Sep;238(3):187-202. doi: 10.1530/JOE-18-0182. Epub 2018 May 24. J Endocrinol. 2018. PMID: 29794231
Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways.
Kurhe Y, Caputo M, Cansby E, Xia Y, Kumari S, Anand SK, Howell BW, Marschall HU, Mahlapuu M. Kurhe Y, et al. Among authors: cansby e. Cell Mol Gastroenterol Hepatol. 2022;13(2):405-423. doi: 10.1016/j.jcmgh.2021.09.018. Epub 2021 Oct 6. Cell Mol Gastroenterol Hepatol. 2022. PMID: 34624527 Free PMC article.
28 results